Compare Fulford India with Abbott India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FULFORD INDIA vs ABBOTT INDIA - Comparison Results

FULFORD INDIA     Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

ABBOTT INDIA 
   Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FULFORD INDIA ABBOTT INDIA FULFORD INDIA/
ABBOTT INDIA
 
P/E (TTM) x 398.8 55.1 723.6% View Chart
P/BV x 6.2 13.3 46.7% View Chart
Dividend Yield % 0.1 0.5 16.4%  

Financials

 FULFORD INDIA   ABBOTT INDIA
EQUITY SHARE DATA
    FULFORD INDIA
Mar-14
ABBOTT INDIA
Mar-19
FULFORD INDIA/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs9428,834 10.7%   
Low Rs4505,458 8.2%   
Sales per share (Unadj.) Rs691.41,731.1 39.9%  
Earnings per share (Unadj.) Rs11.5211.9 5.4%  
Cash flow per share (Unadj.) Rs15.4219.9 7.0%  
Dividends per share (Unadj.) Rs2.0065.00 3.1%  
Dividend yield (eoy) %0.30.9 31.6%  
Book value per share (Unadj.) Rs380.0945.2 40.2%  
Shares outstanding (eoy) m3.9021.25 18.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.04.1 24.4%   
Avg P/E ratio x60.733.7 180.1%  
P/CF ratio (eoy) x45.332.5 139.4%  
Price / Book Value ratio x1.87.6 24.2%  
Dividend payout %17.430.7 56.9%   
Avg Mkt Cap Rs m2,714151,848 1.8%   
No. of employees `0000.43.5 12.7%   
Total wages/salary Rs m5054,356 11.6%   
Avg. sales/employee Rs Th6,073.010,555.5 57.5%   
Avg. wages/employee Rs Th1,137.41,249.9 91.0%   
Avg. net profit/employee Rs Th100.71,292.2 7.8%   
INCOME DATA
Net Sales Rs m2,69636,786 7.3%  
Other income Rs m1251,133 11.1%   
Total revenues Rs m2,82237,919 7.4%   
Gross profit Rs m-466,047 -0.8%  
Depreciation Rs m15169 9.0%   
Interest Rs m1023 42.2%   
Profit before tax Rs m546,989 0.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m102,485 0.4%   
Profit after tax Rs m454,503 1.0%  
Gross profit margin %-1.716.4 -10.5%  
Effective tax rate %17.735.6 49.7%   
Net profit margin %1.712.2 13.5%  
BALANCE SHEET DATA
Current assets Rs m1,73827,610 6.3%   
Current liabilities Rs m5458,569 6.4%   
Net working cap to sales %44.351.8 85.5%  
Current ratio x3.23.2 99.0%  
Inventory Days Days4860 80.5%  
Debtors Days Days427 15.7%  
Net fixed assets Rs m121,057 1.1%   
Share capital Rs m39213 18.4%   
"Free" reserves Rs m1,44319,873 7.3%   
Net worth Rs m1,48220,086 7.4%   
Long term debt Rs m00-   
Total assets Rs m2,07729,409 7.1%  
Interest coverage x6.7311.6 2.2%   
Debt to equity ratio x00-  
Sales to assets ratio x1.31.3 103.8%   
Return on assets %2.615.4 17.0%  
Return on equity %3.022.4 13.5%  
Return on capital %4.334.9 12.3%  
Exports to sales %00-   
Imports to sales %24.50-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m659NA-   
Fx inflow Rs m17369 4.7%   
Fx outflow Rs m6734,918 13.7%   
Net fx Rs m-656-4,549 14.4%   
CASH FLOW
From Operations Rs m904,991 1.8%  
From Investments Rs m105-2,570 -4.1%  
From Financial Activity Rs m-14-1,428 1.0%  
Net Cashflow Rs m181993 18.2%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 75.0 75.0 100.0%  
Indian inst/Mut Fund % 3.8 7.9 48.1%  
FIIs % 0.1 0.1 100.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.2 17.1 124.0%  
Shareholders   4,783 18,270 26.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FULFORD INDIA With:   PROCTER & GAMBLE HEALTH  CIPLA  ASTRAZENECA PHARMA  VENUS REMEDIES  STERLING BIOTECH  

Compare FULFORD INDIA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Witness Selling; Sensex Down 235 Points(12:30 pm)

Share markets in India are presently trading on a negative note. Sectoral indices are trading on a mixed note with stocks in the IT sector.

Related Views on News

PFIZER at All Time High; BSE HEALTHCARE Index Up 0.7% (Market Updates)

Nov 22, 2019 | Updated on Nov 22, 2019

PFIZER share price has hit an all time high at Rs 4,199 (up 1.7%). The BSE HEALTHCARE Index is up by 0.7%. Among the top gainers in the BSE HEALTHCARE Index today are PFIZER (up 1.7%) and ABBOTT INDIA (up 0.6%). The top losers include DR. REDDYS LAB (down 0.1%) and ALKEM LABORATORIES (down 0.3%).

ABBOTT INDIA Announces Quarterly Results (1QFY20); Net Profit Up 41.9% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 41.9% YoY). Sales on the other hand came in at Rs 10 bn (up 18.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (4QFY19); Net Profit Up 13.1% (Quarterly Result Update)

May 28, 2019 | Updated on May 28, 2019

For the quarter ended March 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 13.1% YoY). Sales on the other hand came in at Rs 9 bn (up 15.0% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (3QFY19); Net Profit Up 1.4% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 1.4% YoY). Sales on the other hand came in at Rs 9 bn (up 7.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (2QFY19); Net Profit Up 0.1% (Quarterly Result Update)

Nov 14, 2018 | Updated on Nov 14, 2018

For the quarter ended September 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 0.1% YoY). Sales on the other hand came in at Rs 10 bn (up 5.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

More Views on News

Most Popular

The Smartest Stock to Buy for 2020(Profit Hunter)

Nov 14, 2019

Small-cap stocks are selling at bargain prices today and are poised to generate a lot of wealth in 2020 and beyond...

A Trade that Could Generate Profits for Decades

Nov 14, 2019

India's #1 trader is back on the Investor Hour. Vijay Bhambwani talks to us about his super-profitable trading system and shares with us his #1 long term trade. Listen in...

The One Trade I'm Most Bullish on Now

Nov 12, 2019

A highly specific trade to potentially triple your money in just three months. You won't find this information anywhere else!

How the Modi Government is Helping My Top 7 Stocks(The 5 Minute Wrapup)

Nov 14, 2019

Recent reforms by the Modi government can give a big boost on your stocks, provided you buy the right ones.

I Think Nestle, HUL, and Asian Paints Could Give Low Returns(Profit Hunter)

Nov 15, 2019

If you think high quality stocks will continue their dream run forever, then you must read this now.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

FULFORD INDIA SHARE PRICE


Jul 30, 2015 (Close)

TRACK FULFORD INDIA

  • Track your investment in FULFORD INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FULFORD INDIA 8-QTR ANALYSIS

COMPARE FULFORD INDIA WITH

MARKET STATS